Important Notice for Dentsply Sirona Inc. Shareholders:
New York, NY, January 27, 2025. The Gross Law Firm, a leading securities fraud class action law firm, notifies shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY) that a securities class action lawsuit has been filed against the company. Shareholders who purchased or acquired the securities of Dentsply Sirona Inc. (the “Company”) between February 25, 2021, and October 19, 2022, inclusive (the “Class Period”), are encouraged to contact the firm regarding possible lead plaintiff appointment. The lead plaintiff is a court-appointed representative who acts on behalf of all class members in the class action.
Background:
Dentsply Sirona Inc. is a global dental and medical device company that offers a broad range of products and services, including dental and orthodontic consumables, equipment and technology, as well as implants and other surgical products. The Company operates through its two business segments: Dental and Medical.
Allegations:
The complaint alleges that Dentsply Sirona Inc. and certain of its executives made false and misleading statements to the market. Specifically, the complaint alleges that the defendants failed to disclose that the Company was experiencing lower than anticipated sales growth due to increased competition and pricing pressures. As a result, the Company’s financial statements were materially false and misleading at all relevant times.
Impact on Individual Shareholders:
The filing of this securities class action lawsuit may negatively impact the market price of Dentsply Sirona Inc.’s common stock. As a shareholder of the Company during the Class Period, you may have legal claims and be entitled to compensation for your losses. The lead plaintiff will act on behalf of all class members in seeking to recover damages from the defendants. You may also receive compensation if you sell your shares before the completion of the litigation or if you choose to remain an absent class member.
Impact on the World:
The impact of this securities class action lawsuit on the dental and medical device industry as a whole could be significant. The lawsuit highlights the importance of transparency and accuracy in financial reporting, particularly in the healthcare sector. It also serves as a reminder that companies and their executives must provide accurate and complete information to the investing public. Failure to do so can result in serious consequences, including securities class action lawsuits and damage to the company’s reputation.
Conclusion:
If you are a shareholder of Dentsply Sirona Inc. and purchased or acquired the Company’s securities during the Class Period, we encourage you to contact The Gross Law Firm for a free consultation. Our experienced securities fraud attorneys will review your case and help you understand your legal rights. You may be entitled to compensation for your losses. The Gross Law Firm represents shareholders worldwide and takes pride in its commitment to protecting the rights of its clients.
- Dentsply Sirona Inc. shareholders encouraged to contact The Gross Law Firm
- Securities class action lawsuit filed against the Company
- Allegations of false and misleading statements
- Negative impact on market price of Dentsply Sirona Inc.’s common stock
- Importance of transparency and accuracy in financial reporting
